Pyrazolo(1,5-a)pyrimidine compounds as cannabinoid receptor antagonists

Details for Australian Patent Application No. 2006305104 (hide)

Owner Mitsubishi Tanabe Pharma Corporation

Inventors Moritani, Yasunori; Oi, Mariko; Shirai, Kimihiro

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006305104

PCT Pub. Number WO2007/046548

Priority 2006-151470 31.05.06 JP; 2005-306816 21.10.05 JP; 60/810,149 02.06.06 US; 60/729,206 24.10.05 US

Filing date 20 October 2006

Wipo publication date 26 April 2007

Acceptance publication date 22 October 2009

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

15 May 2008 PCT application entered the National Phase

  PCT publication WO2007/046548 Priority application(s): WO2007/046548

22 October 2009 Application Accepted

  Published as AU-B-2006305104

18 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006305119-Therapeutic agent for heart disease

2006305085-Process for preparation of chiral amlodipine gentisate